EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Harnessing knee joint resident mesenchymal stem cells in cartilage tissue engineering

Xiao Xu, Limei Xu, Jiang Xia, Caining Wen, Yujie Liang, Yuanmin Zhang

Acta Biomaterialia · 2023-09 · 168 · 372-387

DOI: 10.1016/j.actbio.2023.07.024 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Acta Biomaterialia, 2023-09. Verfasst von Xiao Xu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Joint Surgery and Sports Medicine, Affiliated Hospital of Jining Medical University, Jining Medical University, Jining, Shandong 272029…. Hauptthemen laut MEDLINE: Cartilage, Articular, Osteoarthritis, Mesenchymal Stem Cells, Mesenchymal Stem Cell Transplantation. Die Arbeit wurde bisher 85-mal zitiert (Crossref) und nennt 218 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shandong Province, Jining Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteoarthritis (OA) is a widespread clinical disease characterized by cartilage degeneration in middle-aged and elderly people. Currently, there is no effective treatment for OA apart from total joint replacement in advanced stages. Mesenchymal stem cells (MSCs) are a type of adult stem cell with diverse differentiation capabilities and immunomodulatory potentials. MSCs are known to effectively regulate the cartilage microenvironment, promote cartilage regeneration, and alleviate OA symptoms. As a result, they are promising sources of cells for OA therapy. Recent studies have revealed the presence of resident MSCs in synovial fluid, synovial membrane, and articular cartilage, which can be collected as knee joint-derived MSCs (KJD-MSC). Several preclinical and clinical studies have demonstrated that KJD-MSCs have great potential for OA treatment, whether applied alone, in combination with biomaterials, or as exocrine MSCs. In this article, we will review the characteristics of MSCs in the joints, including their cytological characteristics, such as proliferation, cartilage differentiation, and immunomodulatory abilities, as well as the biological function of MSC exosomes. We will also discuss the use of tissue engineering in OA treatment and introduce the concept of a new generation of stem cell-based tissue engineering therapy, including the use of engineering, gene therapy, and gene editing techniques to create KJD-MSCs or KJD-MSC derivative exosomes with improved functionality and targeted delivery. These advances aim to maximize the efficiency of cartilage tissue engineering and provide new strategies to overcome the bottleneck of OA therapy. STATEMENT OF SIGNIFICANCE: This research will provide new insights into the medicinal benefit of Joint resident Mesenchymal Stem Cells (MSCs), specifically on its cartilage tissue engineering ability. Through this review, the community will further realize promoting joint resident mesenchymal stem cells, especially cartilage progenitor/MSC-like progenitor cells (CPSC), as a preventive measure against osteoarthritis and cartilage injury. People and medical institutions may also consider cartilage derived MSC as an alternative approach against cartilage degeneration. Moreover, the discussion presented in this study will convey valuable information for future research that will explore the medicinal benefits of cartilage derived MSC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cartilage, ArticularOsteoarthritisMesenchymal Stem CellsMesenchymal Stem Cell TransplantationAgedAdultMiddle AgedHumansTissue EngineeringKnee Joint

Stichwörter der Autor:innen

Articular cartilageCartilage tissue engineeringKnee joint-resident mesenchymal stem cellsMesenchymal stem cells (MSCs)Osteoarthritis

Autor:innen und Institutionen

  • Department of Joint Surgery and Sports Medicine, Affiliated Hospital of Jining Medical University, Jining Medical University, Jining, Shandong 272029, China; Department of Orthopedics, the First Affiliated Hospital of S…
  • Department of Hematology, Affiliated Hospital of Jining Medical University, Jining Medical University, Jining, Shandong 272029, China.
  • Department of Chemistry, the Chinese University of Hong Kong, Shatin, Hong Kong SAR, China.
  • Department of Joint Surgery and Sports Medicine, Affiliated Hospital of Jining Medical University, Jining Medical University, Jining, Shandong 272029, China.
  • Department of Joint Surgery and Sports Medicine, Affiliated Hospital of Jining Medical University, Jining Medical University, Jining, Shandong 272029, China; Department of Chemistry, the Chinese University of Hong Kong,…
  • Department of Joint Surgery and Sports Medicine, Affiliated Hospital of Jining Medical University, Jining Medical University, Jining, Shandong 272029, China. Electronic address: yuanminzhang@mail.jnmc.edu.cn.

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Shandong Province
  • Jining Medical University
  • National Center for Science and Engineering Statistics

Zitieren

APA

Xu, X., Xu, L., Xia, J., Wen, C., Liang, Y., & Zhang, Y. (2023). Harnessing knee joint resident mesenchymal stem cells in cartilage tissue engineering. Acta Biomaterialia, 168, 372-387. https://doi.org/10.1016/j.actbio.2023.07.024

Vancouver

Xu X, Xu L, Xia J, Wen C, Liang Y, Zhang Y. Harnessing knee joint resident mesenchymal stem cells in cartilage tissue engineering. Acta Biomaterialia. 2023;168:372-387. doi:10.1016/j.actbio.2023.07.024

BibTeX
@article{Xu2023,
  author = {Xu, Xiao and Xu, Limei and Xia, Jiang and Wen, Caining and Liang, Yujie and Zhang, Yuanmin},
  title = {Harnessing knee joint resident mesenchymal stem cells in cartilage tissue engineering},
  journal = {Acta Biomaterialia},
  year = {2023},
  volume = {168},
  pages = {372--387},
  doi = {10.1016/j.actbio.2023.07.024}
}
Kostenlos starten →